Neogen vs its peers
The 10 largest Health Care Supplies companies by market value, prices of Nov 20, 2026
Neogen is the 9th largest of the 10 biggest Health Care Supplies companies on OQRO by market value, at $2.3B. Its revenue of $870M in fiscal 2026 ranks 9th of 10. It runs at an operating loss of 2% of revenue, against a group median margin of 12%. Revenue fell 3% on the year before, against a median of +3.0%.
Side by side
| Company | Market value | Revenue | Growth y/y | 5-yr growth / yr | Gross margin | Operating margin | Net margin | Free cash flow margin | R&D / revenue | Price / earnings | Price / sales | FCF yield | Stock, 12 months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| West Pharmaceutical ServicesWST · FY2025 | $27.2B | $3.07B | +6.3% | +7.4% | 35.9% | 19.0% | 16.1% | 15.3% | 2.4% | 55.1x | 8.8x | 1.7% | +51.4% |
| Cooper Companies (The)COO · FY2025 | $11.2B | $4.09B | +5.1% | +11.0% | 65.5% | 16.7% | 9.2% | 10.6% | 4.2% | 29.9x | 2.7x | 3.9% |
Each company’s latest fiscal year (FY), so the years can end a few months apart. Price ratios divide today’s market value by that year’s figure; price / earnings is left out on a loss. “—” means the company did not tag that line in its annual report.
Operating margin
- LNTH20%
- WST19%
- COO17%
- ALGN14%
- MMSI12%
- HAE12%
- NVST8%
- ICUI2%
- NEOG−2%
Compare Neogen head to head
Where Neogen’s revenue comes from and where it goes: Neogen revenue breakdown. Twenty years of results: Neogen financial history.
Common questions
Who are Neogen's competitors?
The largest companies in its industry (Health Care Supplies) by market value: West Pharmaceutical Services (WST), Cooper Companies (The) (COO), Align Technology (ALGN), Lantheus Holdings (LNTH), Haemonetics (HAE), Merit Medical Systems, Inc. (MMSI), ICU Medical (ICUI), Envista Holdings (NVST) and BioLife Solutions, Inc. (BLFS). They share Neogen's industry listing; not every one competes with it on every product.
Is Neogen bigger than West Pharmaceutical Services?
No, by market value: Neogen is worth $2.3B and West Pharmaceutical Services $27.2B. By revenue, Neogen brought in $870M in fiscal 2026 and West Pharmaceutical Services $3.07B in fiscal 2025.
Where these figures come from
The group is the companies OQRO lists in the same industry as Neogen (Health Care Supplies), the largest 9 by market value, plus Neogen. Companies whose latest annual report is more than a year and a half old, or that report in a currency other than the dollar, are left out.
Revenue, operating income, net income, gross profit, research and development and free cash flow (cash from operations minus capital expenditure) are each company’s own full-year lines from its latest 10-K, as tagged in XBRL (SEC companyfacts). Market value is the last close times the shares outstanding on the latest filing. Price / earnings is market value over net income; price / sales is market value over revenue; free cash flow yield is free cash flow over market value. Five-year growth is the yearly rate that takes revenue from five fiscal years before to the latest. This page describes the past and is not investment advice. No language model wrote it.









